DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04613518 (ClinicalTrials.gov)	November 13, 2020	28/10/2020	A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Subjects With Moderate to Severe Ulcerative Colitis	Colitis, Ulcerative	Drug: BMS-986165 Dose 1;Drug: BMS-986165 Dose 2;Other: Placebo Comparator	Bristol-Myers Squibb	NULL	Not yet recruiting	18 Years	65 Years	All	50	Phase 2	Australia;Canada;Germany;Netherlands;Puerto Rico

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04613518
(ClinicalTrials.gov)

November 13, 2020

28/10/2020

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Subjects With Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative

Drug: BMS-986165 Dose 1;Drug: BMS-986165 Dose 2;Other: Placebo Comparator

Bristol-Myers Squibb

NULL

Not yet recruiting

18 Years

65 Years

All

Phase 2

Australia;Canada;Germany;Netherlands;Puerto Rico